The binding of ZEB1 to the ER-α promoter in breast cancer cells provided further evidence that the downregulation of ER-α by ZEB1 is a possible functional mechanism for eliminating ER-α in ZEB1-positive breast cancer cells. Here, ZEB1 is linked to breast carcinoma.